ursodeoxycholic acid has been researched along with Blood Poisoning in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; He, Z; Li, S; Liu, S; Ma, Y; Wang, W; Wang, Y; Xiao, J; Yang, H; Yang, S; Zhang, S | 1 |
| Chen, WS; Deng, JL; He, YQ; Jiang, SG; Tao, X; Zhang, F; Zhou, CC | 1 |
| Escobar, OH; Frey, MR; Gayer, CP; Golden, JM; Kavarian, P; Mallicote, MU; Nguyen, MVL | 1 |
| Bell, C; Graves, A; Imseis, EM; Mangalat, N | 1 |
| Adam, R; Reinshagen, K; Trunk, M; Wessel, LM | 1 |
| Fickert, P; Geier, A; Trauner, M | 1 |
| Gabe, SM; Lloyd, DA | 1 |
| Btaiche, IF; Khalidi, N | 1 |
| Bäcker, U; Doss, MO; Meessen, D; Schmidt, FW; Wagner, S; Wittekind, C | 1 |
4 review(s) available for ursodeoxycholic acid and Blood Poisoning
| Article | Year |
|---|---|
The chronic liver disease in patients with short bowel syndrome: etiology and treatment.
Topics: Anti-Bacterial Agents; Child; Cholagogues and Choleretics; Cholestasis; Drug Therapy, Combination; Enteral Nutrition; Evidence-Based Medicine; Humans; Infant, Newborn; Infant, Premature; Intestine, Small; Liver Diseases; Parenteral Nutrition; Parenteral Nutrition, Home; Practice Guidelines as Topic; Prognosis; Risk Factors; Sepsis; Short Bowel Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2009 |
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.
Topics: Adrenal Cortex Hormones; Bacterial Infections; Bile; Bile Ducts; Cholestasis; Cytokines; Humans; Liver; Liver Diseases; Liver Transplantation; Nitric Oxide; Sepsis; Ursodeoxycholic Acid | 2006 |
Managing liver dysfunction in parenteral nutrition.
Topics: Anti-Bacterial Agents; Cholestasis; Enteral Nutrition; Humans; Liver Diseases; Parenteral Nutrition; Risk Factors; Sepsis; Ursodeoxycholic Acid | 2007 |
Parenteral nutrition-associated liver complications in children.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Bilirubin; Carnitine; Child; Cholestasis; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Parenteral Nutrition; Sepsis; Sincalide; Taurine; Ursodeoxycholic Acid | 2002 |
5 other study(ies) available for ursodeoxycholic acid and Blood Poisoning
| Article | Year |
|---|---|
Gut microbiota-derived ursodeoxycholic acid from neonatal dairy calves improves intestinal homeostasis and colitis to attenuate extended-spectrum β-lactamase-producing enteroaggregative Escherichia coli infection.
Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Caco-2 Cells; Cattle; Colitis; Diarrhea; Escherichia coli; Escherichia coli Infections; Gastrointestinal Microbiome; Homeostasis; Humans; Mice; Sepsis; Ursodeoxycholic Acid | 2022 |
Ursodeoxycholic acid alleviates sepsis-induced lung injury by blocking PANoptosis via STING pathway.
Topics: Acute Lung Injury; Animals; Cell Death; Inflammation; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Oxidative Stress; Sepsis; Ursodeoxycholic Acid | 2023 |
Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms.
Topics: Animals; Bile Acids and Salts; Cell Movement; Cholagogues and Choleretics; Cyclooxygenase 2; Disease Models, Animal; Enterocytes; ErbB Receptors; Intestinal Diseases; Mice; Protective Factors; Sepsis; Ursodeoxycholic Acid | 2018 |
Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation.
Topics: Bilirubin; Cholagogues and Choleretics; Cholestasis; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Parenteral Nutrition; Retrospective Studies; Sepsis; Time Factors; Ursodeoxycholic Acid; Withholding Treatment | 2014 |
[Erythrohepatic protoporphyria with rapidly progressing liver cirrhosis].
Topics: Cholestyramine Resin; Humans; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Multiple Organ Failure; Porphyrias; Porphyrins; Protoporphyrins; Sepsis; Ursodeoxycholic Acid | 1989 |